Skip to content

Author

M. S. Ribeiro

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Perioperative empagliflozin and risk of acute kidney injury after cardiac surgery: a systematic review and meta-analysis

Hypertension is the leading modifiable risk factor for cardiovascular disease globally, driven by a sodium-rich, potassium-poor dietary phenotype. Whilst potassium-enriched salt substitutes (PESS) demonstrate hypotensive potential, widespread clinical implementation is hindered by theoretical concerns regarding f...

G. Â. Alves, T. Bonafé, B. Souza et al. · 0 citations
Review Open access Oct 2026

Efficacy and safety of zilebesiran for inadequately controlled hypertension: a systematic review and meta-analysis

Hypertension remains the leading modifiable risk factor for cardiovascular disease, yet control rates are suboptimal due to poor adherence and blood pressure (BP) variability with daily oral regimens. Zilebesiran is an investigational RNA interference therapeutic targeting hepatic angiotensinogen (AGT) synthesis....

T. Bonafé, G. A. Alves, B. M. Gomes et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.